NCT01528891View on ClinicalTrials.gov

Dexmedetomidine as a Rapid Bolus in Children for Emergence Agitation

PHASE3CompletedINTERVENTIONAL
Enrollment

418

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

August 31, 2014

Study Completion Date

August 31, 2014

Conditions
Tonsillectomy
Interventions
DRUG

Dexmedetomidine

0.5 micrograms/Kilogram one time bolus 5 minutes prior to the end of surgery

OTHER

Placebo

Trial Locations (2)

15224

Children's Hospital of Pittsburgh, Pittsburgh

Childrens Hospital of Pittsburgh, Pittsburgh

All Listed Sponsors
collaborator

Hospira, now a wholly owned subsidiary of Pfizer

INDUSTRY

lead

Peter Davis

OTHER

NCT01528891 - Dexmedetomidine as a Rapid Bolus in Children for Emergence Agitation | Biotech Hunter | Biotech Hunter